Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) Aworan Ifihan Didara to gaju

Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) Didara to gaju

Apejuwe kukuru:

Orukọ Kemikali: Ethyl Nipecotate

CAS: 5006-62-2

Irisi: Alailowaya si Pale Yellow Liquid

Ayẹwo: ≥99.0% (GC)

Didara to gaju, iṣelọpọ Iṣowo

E-mail: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese pẹlu Iwa mimọ giga ati Didara Idurosinsin
Orukọ Kemikali: Ethyl Nipecotate
CAS: 5006-62-2
Didara to gaju, iṣelọpọ Iṣowo

Kemikali Properties:

Orukọ Kemikali	Ethyl Nipecotate
Awọn itumọ ọrọ sisọ	Ethyl 3-Piperidinecarboxylate;Ethyl piperidine-3-carboxylate;3-Piperidinecarboxylic Acid Ethyl Ester
Nọmba CAS	5006-62-2
NỌMBA CAT	RF-PI271
Iṣura Ipo	Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular	C8H15NO2
Òṣuwọn Molikula	157.21
Ojuami Iyo	165.0 ~ 167.0 ℃
Ojuami farabale	102-104℃ / 7 mmHg (tan.)
iwuwo	1.012 g/ml ni 25 ℃ (tan.)
Atọka Refractive	n20/D 1.460 (tan.)
Omi Solubility	Iyatọ
Sowo Ipò	Sowo Labẹ Ibaramu otutu
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Ailokun to Bia Yellow Liquid
Omi	≤0.50%
Nikan Aimọ	≤0.50%
Lapapọ Awọn Aimọ	≤1.0%
Awọn Irin Eru	≤20ppm
Ayẹwo	≥99.0%
Igbeyewo Standard	Standard Enterprise
Lilo	elegbogi Intermediates

Package & Ibi ipamọ:

Package: Igo, Barrel, 25kg/Barrel, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.

Awọn anfani:

FAQ:

Ohun elo:

Shanghai Ruifu Kemikali Co., Ltd. jẹ olupilẹṣẹ asiwaju ati olupese ti Ethyl Nipecotate (CAS: 5006-62-2) pẹlu didara to gaju, ti a lo ni lilo pupọ ni iṣelọpọ Organic, iṣelọpọ ti awọn agbedemeji elegbogi ati iṣelọpọ Elegbogi Ti nṣiṣe lọwọ (API).

Ohun elo Ethyl Nipecotate (CAS: 5006-62-2) ni a lo ninu iṣelọpọ ti: α, α′-bis [3- (N, N-diethylcarbamoyl) -piperidino] -p-xylene;2-amino-4-thiazolyl itọsẹ ti 3- (iso-propyl-3-piperidinyl) phenol;

Reactant fun kolaginni ti: Squalene synthase inhibitors;4-aminomethyl-7,8-dihydroxycoumarines ati awọn itọsẹ ether ade wọn;Spiroimidazolidinone NPC1L1 inhibitors;Awọn oluyipada ti oye Quorum;Yiyan serotonin 5-HT6 antagonists olugba;Oxazolidinone RNA-abuda òjíṣẹ.